UC Irvine

This Week in PLOS

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Extra Variation

A new fruit fly genome sequence has uncovered additional variation that affects key fly traits.

Still Evolving

A new paper in PNAS finds that people are still evolving, but with increased pressure on weight and decreased pressure on intelligence.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

The funding will, in part, support efforts to expand the project's catalog of functional elements and understand their roles in different contexts.

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

The projects focus on early treatment of prostate cancer and cataloguing mutations in difficult-to-diagnose diseases, among other things. 

The funding is part of the NHGRI Genome Technology Program, which promotes new methods, technology, and instruments for sequencing and functional genomics.

The technology uses DNAzyme-based sensors, fluorescent biomarkers, and a high-throughput particle counter to rapid identify rare targets in complex raw samples.

The scientists have adapted a technology first developed in fruit flies to spread malarial resistance genes in the Asian mosquito species A. stephensi.

Pages

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.